Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Coccidian mitochondrial electron transport chain (ETC) is a vital metabolic system in apicomplexan parasites, including Eimeria and Toxoplasma species, responsible for generating ATP and maintaining the mitochondrial membrane potential (Mather et al., 2007). This system is distinct from its mammalian counterpart due to the presence of unique enzymes and structural variations in the cytochrome bc1 complex (Complex III), which serves as a primary site for therapeutic intervention (Vaidya & Mather, 2009). Drugs such as decoquinate and atovaquone selectively bind to the ubiquinone-binding site of the bc1 complex, effectively halting electron flow and inducing a lethal energy crisis in the parasite (Wang, 1975). Additionally, the ETC is functionally linked to pyrimidine biosynthesis through the enzyme dihydroorotate dehydrogenase, meaning its inhibition also disrupts DNA synthesis. Toltrazuril and its derivatives further target this system, causing mitochondrial swelling and interfering with the parasite's ability to divide (Harder & Haberkorn, 1989). Consequently, the coccidian ETC is a cornerstone target for the prevention and treatment of coccidiosis in poultry and livestock, as well as various protozoal diseases in other animals.
Inhibition of the mitochondrial electron transport chain, primarily at the cytochrome bc1 complex (Complex III), which disrupts the proton gradient, halts ATP synthesis, and interferes with essential metabolic pathways such as pyrimidine biosynthesis.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coccidian mitochondrial electron transport chain (ETC).